Skip to main content
. 2016 Oct 17;6:35281. doi: 10.1038/srep35281

Table 5. Single and joint analyte analysis on the association between Riboflavin and FMN and OSCC and GCA.

Site Stratification Model including riboflavin Model including FMN Model including (riboflavin + FMN)
Riboflavin FMN Riboflavin FMN
β HRa 95% CI β HRa 95% CI β HRa 95% CI β HRa 95% CI
OSCC Overall −0.06145 0.94 0.90 to 0.98 0.04936 1.05 0.98 to 1.12 −0.07720 0.93 0.88 to 0.97 0.08037 1.08 1.01 to 1.16
  Factor B recipients −0.05308 0.95 0.88 to 1.02 0.1123 1.12 1.02 to 1.23 −0.07975 0.92 0.86 to 0.99 0.1421 1.15 1.04 to 1.28
  Factor B non-recipients −0.07031 0.93 0.88 to 0.99 −0.00958 0.99 0.90 to 1.09 −0.07830 0.92 0.87 to 0.99 0.02313 1.02 0.93 to 1.13
GCA Overall −0.03049 0.97 0.92 to 1.03 0.05572 1.06 0.97 to 1.15 −0.04251 0.96 0.90 to 1.02 0.08883 1.09 1.00 to 1.20
  Factor B recipients 0.001703 1.00 0.92 to 1.09 0.06574 1.07 0.94 to 1.21 −0.01375 0.99 0.91 to 1.07 0.1027 1.11 0.97 to 1.26
  Factor B non-recipients −0.05729 0.94 0.87 to 1.03 0.02996 1.03 0.91 to 1.16 −0.06492 0.94 0.86 to 1.02 0.05851 1.06 0.93 to 1.20

aHRs and 95% CIs were calculated using models adjusted for age, sex, cigarette smoking, alcohol drinking, and BMI. Overall models were also adjusted for receipt of Factor B. Continuous HRs were scaled to one-half IQR, which was 4.22 nmol/L for riboflavin, and 4.71 nmol/L for FMN, respectively.